1-3 of 3
Judit Rejtö
Close
Sort by
Journal Articles

Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors

Clinical Trials & Observations
Helmut Schweiger, Judit Rejtő, Christoph J. Hofbauer, Verena Berg, Peter Allacher, Karl Zwiauer, Clemens Feistritzer, Gerhard Schuster, Cihan Ay, Birgit M. Reipert, Ingrid Pabinger
Journal: Blood Advances
Blood Adv (2022) 6 (3): 946–958.
https://doi.org/10.1182/bloodadvances.2021005745
Published: 2022
Includes: Supplemental data
Journal Articles

Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency

Clinical Trials & Observations
Dino Mehic, Alexander Tolios, Stefanie Hofer, Cihan Ay, Helmuth Haslacher, Judit Rejtö, Willem H. Ouwehand, Kate Downes, Matthias Haimel, Ingrid Pabinger, Johanna Gebhart
Journal: Blood Advances
Blood Adv (2021) 5 (2): 391–398.
https://doi.org/10.1182/bloodadvances.2020003464
Published: 2021
Includes: Supplemental data
Journal Articles

Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause

Clinical Trials & Observations
Dino Mehic, Stefanie Hofer, Christof Jungbauer, Alexandra Kaider, Helmuth Haslacher, Ernst Eigenbauer, Judit Rejtő, Dieter Schwartz, Bernd Jilma, Cihan Ay, Ingrid Pabinger, Johanna Gebhart
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5157–5164.
https://doi.org/10.1182/bloodadvances.2020002452
Published: 2020
Includes: Supplemental data